Health care industry
Hinge Health says revenue increased 50% in first quarter — still no price range for IPO
Hinge Health’s TrueMotion feature. Courtesy: Hinge Health Hinge Health on Monday updated its prospectus to include the results from its first quarter, which showed accelerating revenue growth over its fourth quarter. The digital physical therapy startup filed to go public in March, but it has not shared a price range yet. Hinge said that revenue […]
Read More
Hims & Hers gives weak outlook but says more collaborations are coming
Shares of Hims & Hers Health fell in extended trading on Monday after the company reported first-quarter earnings that beat analysts’ expectations but offered weaker-than-expected guidance. Here’s how the company did based on average analysts’ estimates compiled by LSEG: Earnings per share: 20 cents vs. 12 cents Revenue: $586 million vs. $538 million Revenue at […]
Read More
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
US President Donald Trump speaks during a cabinet meeting in the Cabinet Room of the White House in Washington, DC, on April 30, 2025. Jim Watson | Afp | Getty Images President Donald Trump on Monday signed an executive order to incentivize drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build […]
Read More
Democratic-led states sue to prevent Trump from gutting health agencies
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. discusses the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, during a press conference at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters […]
Read More
Function Health buys Ezra, launches full-body scan for a third of the price
Jonathan Swerdlin, co-founder and CEO of Function Health. Courtesy of Function Health. Blood testing startup Function Health on Monday announced the acquisition of full-body MRI scanning company Ezra and launched a new, 22-minute scan for $499. Function offers a $499 annual subscription where members complete more than 160 blood tests and track their results over […]
Read More
Hims & Hers brings former Amazon executive into C-suite
Bringing nearly 20 years of global experience at Amazon, Nader Kabbani is joining the executive leadership team to help the company further innovate on the delivery of affordable, seamless personalized care in the U.S. and globally. Courtesy: Hims & Hers Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped […]
Read More
From ‘Cockroach Award’ to the Big Board: Hinge Health’s unlikely path to IPO
Hinge Health co-founders Gabriel Mecklenburg (left) and Daniel Perez (right). Courtesy of Hinge Health At digital physical therapy startup Hinge Health, CEO Daniel Perez used to recognize hard-working employees with the “Cockroach Award,” a distinction that brought with it a “cockroach squad” t-shirt and a cash payout. References to the insect were abundant at the […]
Read More
CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its […]
Read More
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to charges related to a recent cancer treatment deal. The pharmaceutical giant now expects its adjusted fiscal 2025 earnings to come in between $20.78 and $22.28 […]
Read More
Eli Lilly CEO says company can help ‘respond’ to national security concerns around essential drugs as tariffs loom
CEO of Eli Lilly and Company David Ricks speaks at the Economic Club of New York on March 12, 2024 in New York City. Spencer Platt | Getty Images Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help “respond” to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom. The […]
Read More